Northwestern University Feinberg School of Medicine
Department of Medicine

Hematology and Oncology

About Us

The Division of Hematology and Oncology is focused on improving patients’ therapeutic options and quality of life while working to better prevent, diagnose and treat cancer and hematologic disorders.

“Our division houses laboratory-based investigators focused on a broad array of topics, including chemoprevention, cell signal pathways, epigenetics, immune-modulation, and nanotechnology theranostics.”

– William J. Gradishar, MD

Read Message from the Chief

What We Do

Faculty: Meet the Team

View individual profiles of our faculty members and learn about their research and clinical specialties.

See All Faculty

Al B Benson, MD

Professor of Medicine (Hematology and Oncology)

Colon cancer, Gastric cancer, Pancreas cancer, Rectal cancer

Hidayatullah G Munshi, MD

Associate Professor of Medicine (Hematology and Oncology)

Pancreatic cancer remains the most lethal human malignancy because of early metastasis and lack of significant response to current therapies. Since human pancreatic tumors are associated with a pronounced fibrotic reaction, my lab has been interested in understanding how this fibrosis contributes to pancreatic cancer progression: 1. Understand how fibrosis regulates pancreatic cancer invasion and metastasis. We have evaluated the role of proteases in pancreatic cancer progression using in vitro and in vivo models. Since epithelial-mesenchymal transition (EMT) contributes to cancer progression...

Sunandana  Chandra, MD, MS

Assistant Professor of Medicine (Hematology and Oncology)

I have an interest in the development of clinical trials, as well as studying novel biomarkers that may be used as prognostic and predictive tools in the management of melanoma and other advanced skin cancers, as well as cancer of unknown primary.

Mary F Mulcahy, MD

Professor of Medicine (Hematology and Oncology), Radiology and Surgery (Organ Transplantation)

Colon cancer, Esophagus cancer, Gastric cancer, Hepatocellular cancer, Pancreas cancer, Rectal cancer

Jindan  Yu, MD, PhD

Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics

The primary research focus of the lab is to understand aberrant transcriptional and epigenetic regulation of prostate cancer. We utilize high-throughput genomic techniques in combination with bioinformatics/statistical analysis to generate hypothetical concepts. We then test these hypotheses using traditional molecular or cellular biological approaches and examine the functional relevance of innovative mechanisms using in vitro cell line and in vivo mouse models. Transcription factors of particular interest to us include androgen receptor (AR), FoxA1, Polycomb group protein (EZH2), and the ...

Barbara  Pro, MD

Professor of Medicine (Hematology and Oncology)

Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Clinical trials

Jayesh  Mehta, MD

Professor of Medicine (Hematology and Oncology)

Myeloma, Transplantation

Derek A Wainwright, PhD

Assistant Professor of Neurological Surgery, Medicine (Hematology and Oncology) and Microbiology-Immunology

Our laboratory utilizes DNA sequencing, gene expression profiling, proteomic analyses, flow cytometric methodology and many other basic techniques to pursue goals that are ultimately translatable for improving health and overall survival in patients with brain cancer. Although our research is primarily focused on malignant glioma, with a special emphasis on glioblastoma, we are also interested in pursuing incurable pediatric brain tumors, as well as metastatic tumors that invade the brain/spinal cord. It is our sincere hope that, the basic mechanistic investigations that we carry out, uncover ...

Panagiotis  Ntziachristos, PhD

Assistant Professor of Biochemistry and Molecular Genetics and Medicine (Hematology and Oncology)

The Ntziachristos laboratory studies the mechanistic aspects of oncogenesis with an emphasis on transcriptional and epigenetic regulation of acute leukemia. Up to 25% of children with Acute Lymphoblastic Leukemia will fail frontline therapy and their prognosis is dismal. Cure rates for patients relapsing on therapy are approximate 20%. While patients with later relapses have a better prognosis, the majority eventually succumbs to the disease (overall cure rate 40 to 50%). Important questions in our laboratory are related to how oncogenes interact with each other and with epigenetic modulator...

Aparna  Kalyan, MBBS

Assistant Professor of Medicine (Hematology and Oncology)

My primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. I am interested in incorporating immunotherapy and molecular testing into clinical trials.

Contact Us

We welcome your questions and comments.

Learn More

Diversity and Inclusion

The department works toward an environment of inclusion and support through the Diversity and Cultural Affairs Council and through several dedicated events and initiatives.

Learn More

Housestaff Research Portal

Graduate Research Resources

We offer a wide range of resources, mentorship opportunities and training to help our residents and fellows excel as physician-scientists. Explore all of the resources and hear from housestaff who are making research a major part of their career development plans.

Visit the Housestaff Research Portal

Giving

Support What We Do

Terri Dillon

We invite your philanthropic partnership in helping us achieve our research and teaching missions each day.

Make an online donation

Contact Terri Dillon for more information on supporting the Division of Hematology-Oncology at 312-503-4837 or terri-dillon@northwestern.edu.

Back to top